Long-Term Vascular Response to Everolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study

Trial Profile

Long-Term Vascular Response to Everolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2015

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top